期刊文献+

乳腺癌前哨淋巴结显像的临床价值 被引量:3

The clinical value of mammary sentinel lymphoscintigraphy in breast cancer
暂未订购
导出
摘要 目的:探讨乳腺癌前哨淋巴结(SLN)显像的临床价值。方法:91例T1-2N0期乳腺肿瘤术前或局部手术后在患者瘤体上方的皮下注射了99mTc-人血清白蛋白(55.5 MBq/0.5ml)或在瘤周乳腺组织注射99mTc-硫胶体(92.5 MBq,/4ml),其中63例进行了乳腺淋巴显像,70例于注射后2-16小时、在腋淋巴清扫术前进行了术中γ探头引导下的乳腺SLN活检。结果:两种示踪剂均能快速显示淋巴结,以0.5h显像结果为准,SLN显像成功率为81%(51/63),13.7%(7/51)的SLN放射性强度低于第二个淋巴结,其中证实85.7%(6/7)存在转移。乳腺内、外侧部肿瘤的内乳SLN出现率为38.5%(5/13)、26.3%(10/38)。SLN活检成功率为95.7%(67/70),SLN数量1.6±1.1只(1-5只)。SLN预测腋窝淋巴结转移的灵敏度、特异性、准确性、PPV和NPV分别为82.75%(24/29)、100%(38/38)、92.53%(62/67)、100%(24/24)和88.37%(38/43)。结论:乳腺前哨淋巴结显像可以了解所显淋巴结的质与量以帮助活检者正确定位SLN,观察乳腺癌淋巴引流个体变异以引导活检部位和制定辅助治疗方案。 Purpose: To evaluate the clinical value of mammary sentinel lymphoscintigraphy in breast cancer. Methods: 91 patients with breast cancer in stage T1-2N0 were injected with 55. 5MBq/0. 5ml 99mTc- human serum albumin on the surface of the lesion subdermally or 92. 5MBq/4ml unfiltered 99mTc-sulfur colloid in four divided doses around the lesion. 63 patients underwent mammary lymphoscintigraphy and sentinel node biopsy using a hand-held r-ray detector probe were performed 2 - 16 hr postinjection in 70 patients during breast surgery . Results: The sentinel lymph node( s) (SLN) could quickly be shown by these two tracers in 81% (51/63) cases . A SLN with low activity could be seen in 13. 7% (7/5.1) cases , in which 85.7%(6/7) were proved to have a metastasis. Lymph drainage to the internal mammary nodes occurred in 38. 5% (5/13) of patients with an inner-lesion and in 26. 3% (10/38) of patients with an outer-lesion . The SLN was successfully identified in 95. 7% (67/70) of the patients and the number of the nodes ranged from 1 -5 with an average 1. 6 per person . The accuracy of the SLN with respect to the positive or negative status of the axillary nodes was 92.53% (62/67) . The sensitivity , specificity, PPV, NPV of the method was 82.75% (24/29), 100% (38/38), 100% (24/24) and 88. 37% (38/43), respectively . Conclusions: Mammary lymphoscintigraphy in breast cancer is helpful for localizing SLN correctly and identifying abnormal lymph drainage.
出处 《中国癌症杂志》 CAS CSCD 2002年第6期530-534,共5页 China Oncology
关键词 乳腺癌 前哨淋巴结 淋巴显像 术中γ探测 breast cancer sentinel node lymphoscintigraphy intraoperative gamma probe
  • 相关文献

参考文献12

  • 1尼尔马,沈坤炜,韩企夏,邵志敏,吴炅,陆劲松,张家新,柳光宇,庄传经,沈镇宙,杜会锋,章英剑.乳腺癌前哨淋巴结活检30例分析[J].中国癌症杂志,2000,10(6):481-484. 被引量:23
  • 2Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer[ J]. J Nucl Med, 1995,38(10) :1775 ~ 1780.
  • 3Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [ J ]. Lancet, 1997,349:1864 ~ 1867.
  • 4Gulec SA, Moffat FL, Carroll RG, et al. Sentinel lymph node localization in early breast cancer [ J ]. J Nucl Med, 1998,39(8) :1388 ~ 1393.
  • 5Valdes ORA, Hoefnagel CA, Nieweg OE, et al.Lymphoscintigraphy in oncology: a rediscovered challenge [ J ].Eur J Nucl Med, 1999(supp), s2 ~ s10(abstract).
  • 6Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and periareolar blue method [ J ]. Ann Surg, 2000,232(1):81 ~89.
  • 7Uren RF, Howman-Giles RB, Thompson JF, et al . Mammary Lymphoscintigraphy in Breast Cancer[J]. J Nucl Med,1995,36(10) :1775 ~ 1780.
  • 8Giuliano AE, Kirgan DM, Guenther JM, et al . Lymphatic mapping and sentinel lymphadenectomy for breast cancer [ J ].Ann Surg, 1994,220: 391 ~ 401.
  • 9Krag D, Weaver D, Askikaga T, et al. The Sentinel node in breast cancer multicentre validation study [ J ]. N Engl J Med,1998,339 ( 14 ) :941 ~ 946.
  • 10Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer[ J]. Semin in Nucl Med, 1999,29( 1 ) :57 ~ 68.

二级参考文献9

  • 1KragDN,WeaverDL,AlexJC,etal.SurgicalresectionandradiolocalisationofthesentinelnodeinBreastCancerusingaGammaprobe[J].SurgOncol,1993,2(6):335-339.
  • 2GiulianoAE,KeganDM,GuentherJM,etal.Lymphaticmappingandsentinellymphadenectomyforbreastcancer[J].AnnSurg,1994,220:391-401.
  • 3VeronesiU,PaganelliG,GalimbertiJM,etal.Sentinalnodebiopsytoavoidaxillarydissectioninbreastcancerwithclinicallynegativelymphnodes[J].Lancet,1997,349(9069):1864-1867.
  • 4GiulianoAE,HaighPI,BrennanMB,etal.Prospectiveobservationalstudyofsentinellymphadenectomywithoutfurtheraxillarydissectioninpatientswithsentinelnodenegativebreastcancer[J].JClinOncol,2000,18(13):2553-2559.
  • 5CoxCE,PendasS,CoxJM,etal.Guidelinesforsentinelbiopsyandlymphaticmappingofpatientswithbreastcancer[J].AnnSurg,1998,227(5):645-651.
  • 6McMasterKM,TuttleTM,CarlsonDJ,etal.Sentinallymphnodebiopsyforbreastcancer:Asuitablealternativetoroutineaxillarydissectioninmulti-institutionalpracticewhenoptimaltechniqueisused[J].JClinOncol,2000,18(13):2560-2566.
  • 7O'HeaBJ,HillADK,El-shirbinyAM,etal.Sentinellymphnodebiopsyinbreastcancer:initialexperienceatmemorialsloan-ketteringcancercenter[J].JAmCollSurg,1998,186(4):423-427.
  • 8KragD,WeaverD,AskikagaT,etal.Thesentinelnodeinbreastcancermulticentrevalidationstudy[J].NEnglJMed,1998,339(14):941-946.
  • 9McintoshA,PurushothamAD.Lymphaticmappingandsentinelnodebiopsyinbreastcancer[J].BrJSurg,1998,85:1347-1376.

共引文献22

同被引文献19

  • 1刘欢,翟锦,江雷.纳米材料的自组装研究进展[J].无机化学学报,2006,22(4):585-597. 被引量:33
  • 2Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Semin in Nucl Med, 1999, 29: 57-68.
  • 3Krag D, Weaver D, Askikaga T, et al. The sentinel node in breast cancer multicentre validation study. N Engl J Med, 1998, 339: 941-946.
  • 4Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes, lancet, 1997, 349: 1864-1867.
  • 5Gulec SA, Moffat FL, Carroll RG, et al. Sentinel lymph node localization in early breast cancer. J Nucl Med, 1998, 39: 1388-1393.
  • 6Schmidt MS,Gardner PM,Redlich PN,et al. Breast lymphoscintigraphy:high-volume injection technique improves sentinel lymph node visualization. J Nud Med, 1998, 39: 25P.
  • 7Imoto S, Hasebe T. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Hospital East. Jpn Clin Oncol, 1999, 29:11-15.
  • 8Waddington WA, Keshtgar MR, Taylor I, et al. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nud Med, 2000,27: 377-391.
  • 9Uren RF, Howrman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med, 1995, 38: 1775-1780.
  • 10Bellon JR, Byrd DR, Dunnwald LK. FDG PET and lymphoscintigraphy:towards a comprehensive evaluation of the internal mammary lymph nodes(Abstract). Breast Cancer Res Treat, 2000, 64: 30.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部